Similar articles

• Magnetic resonance cholangiopancreatography (MRCP) for suspected bilio-pancreatic disease: should the endoscopist take a second look?

  Wehrmann T, Eckardt AJ, Riphaus A. Wehrmann T, et al. Z Gastroenterol. 2013 Feb;51(2):204-8. doi: 10.1055/s-0032-1325377. Epub 2013 Feb 15. Z Gastroenterol. 2013. PMID: 23417365
• [Quality rating of MR-cholangiopancreatography with oral application of iron oxide particles].

  Lorenzen M, Wedegärtner U, Fiehler J, Adam G. Lorenzen M, et al. Rofo. 2003 Jul;175(7):936-41. doi: 10.1055/s-2003-40439. Rofo. 2003. PMID: 12847648 Clinical Trial. German.
• [MRCP (magnetic resonance cholangiopancreatography)--an assessment of current status].

  Merkle EM, Nüssle K, Glasbrenner B, Tomczak R, Preclik G, Rieber A, Adler G, Brambs HJ. Merkle EM, et al. Z Gastroenterol. 1998 Mar;36(3):215-24. Z Gastroenterol. 1998. PMID: 9577905 Review. German.
• Malignant biliary obstruction: value of imaging findings.

  Stroszczynski C, Hunerbein M. Stroszczynski C, et al. Abdom Imaging. 2005 May-Jun;30(3):314-23. doi: 10.1007/s00261-004-0251-y. Abdom Imaging. 2005. PMID: 15965779 Review.
• [The usefulness of MRCP in the initial diagnosis of the biliary and pancreatic diseases compared with ERCP].

  Iwano M, Mukai H, Mizuma Y, Takino T, Ashihara T, Ueda T, Matumura S, Fujita T, Takano Y, Fujiwara H, Watanabe A, Masuzawa A. Iwano M, et al. Nihon Rinsho. 1998 Nov;56(11):2880-4. Nihon Rinsho. 1998. PMID: 9847614 Japanese.